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Summary
Purpose: Serum hyaluronan (HA) was evaluated for diurnal variation in participants with osteoarthritis (OA) of the knee.
Methods: Twenty participants with radiographic OA of at least one knee were admitted overnight to the General Clinical Research Center for
serial serum sampling. Serum was obtained between 6:00 p.m. and 8:00 p.m. on Day 1 (T3) after a day of normal activity. During the night of
bed rest, participants remained supine for a minimum of 5 h between the hours of 3:00 a.m. and 8:00 a.m. Blood was drawn prior to arising
from bed (T0), and 1 h (T1) and 4 h (T2) after arising and performing usual morning activities, including eating breakfast. During the morning,
participants were encouraged to remain physically active and were not permitted to sit for more than 30 min at a time. Serum HA was
measured by enzyme-linked immunosorbent assay. Results were analyzed using non-parametric Freidman’s test with Dunn’s post-hoc
Multiple Comparison test.
Results: Serum levels of HA increased signiﬁcantly from T0 to T1 (P! 0.01). There were no other signiﬁcant changes in serum HA levels
observed between any of the other time points.
Conclusions: Although a rise in serum HA with activity and eating has been demonstrated previously in individuals with rheumatoid arthritis,
this is the ﬁrst study to demonstrate a similar rise in individuals with OA. These results suggest that serum sampling for HA in OA clinical trials
should be performed more than 1 h after arising in the morning and at least 1 h after breaking an overnight fast.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Serum hyaluronan (HA) is a marker of osteoarthritis (OA)
status1,2. HA is a high molecular weight glycosaminoglycan,
composed of alternating subunits of glucosamine and
glucuronic acid. The strong association of serum HA with
OA is somewhat surprising given the widespread distribu-
tion of HA as a constituent of loose connective tissue
throughout the body. HA is however present in high
concentrations in joint tissues including synovium, cartilage,
and synovial ﬂuid.
The majority of HA (85%) is cleared from joints by way of
lymphatics with the remainder cleared by the liver via the
general circulation3,4. The daily variation in serum HA, and
optimal sampling procedure, has not previously been
evaluated in the setting of OA. In rheumatoid arthritis
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association with activity5,6, and as a function of synovial
mass7. Healthy controls have been shown to have low
baseline concentrations of serum HA which increase up to
two times baseline levels with activity5,6,8 (Table I).
However, no elevation in serum HA has been seen with
activity in a reference group of hospitalized patients with
other non-arthritic diseases which included glaucoma,
orbital tumor, mycosis fungoides, and polymorphous light
eruption8. We were interested in determining whether
diurnal and activity related variation in serum HA was
evident in OA, a joint disease typically characterized by less
overt and less frequent episodes of synovitis than RA.
Methods
PARTICIPANTS
Participants with radiographic knee OA of at least one
knee were recruited through the Rheumatology outpatient
clinic. Participants were excluded on the basis of arthrop-
athy due to RA, systemic lupus erythematosus, psoriasis,
gout, or hemochromatosis. Based upon self-report, no
participant in our study had liver disease, a cause of
elevated serum HA levels. All procedures were approved by
the Institutional Review Board of Duke University Medical
Center. Participants were admitted to the General Clinical7
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Summary of studies evaluating daily variation in serum HA levels in individuals with arthritis
Study Mean serum HA
after bed rest (ng/ml)
Mean serum HA after
morning activities (ng/ml)
Magnitude increase
in HA with activity*
ELISA method
Engstro¨m-Laurent et al.5 Controls: 26 Controls: 54 2.08 Afﬁnity method
RA: 124 RA: 402 3.24
Lindqvist et al.8 Controls: 65 Controls: 93 1.43 Competitive
radioimmunoassayRA: 196 RA: 1183 6.04
Manicourt et al.6 Controls: 32 Controls: 62 1.94 Sandwich ELISA
RA: 69 RA: 173 2.51
Present study OA: 69 OA: 136 1.98 Competitive ELISA
*P! 0.01 for change with activity for each group in each study.Research Center (GCRC) of Duke University Medical
Center in the late afternoon for an overnight stay. Partic-
ipants were allowed to take all of their usual medications,
including non-steroidal anti-inﬂammatory drugs and dietary
supplements such as vitamins and glucosamine and/or
chondroitin sulfate.
OA ASSESSMENT
On the day of admission, weight-bearing, 30(semiﬂexed
posteroanterior radiographs of both knees were taken with
the SynaFlex x-ray positioning frame (Synarc, San
Francisco, CA)9. Knee radiographs were scored for
KellgreneLawrence (KeL) grade10 by the consensus of
two trained observers. Knee OA was quantiﬁed as the sum
of the KeL grades for both knees, and totaled R 2 for each
participant. Four participants had undergone unilateral total
knee replacement and the replaced knee was assigned
a KeL score of 0 for purposes of analysis. Hip OA was
deﬁned clinically by physician assessment based upon
ACR criteria: hip pain with either (1) internal hip rotation
!15( degrees and hip ﬂexion %115(, or (2) internal hip
rotation R15(, pain associated with internal rotation,
morning stiffness of the hip of %60 min, and age over 50
years11. The number of affected hips was recorded as 0, 1,
or 2. The total number of knees with radiographic OA and
hips with clinical OA was summed as 1, 2, 3, or 4 joints.
CLINICAL VARIABLES
Morning stiffness of the knees was quantiﬁed on a 0e3
scale as follows: 0 (none), 1 (up to 30 min), 2 (31e60 min),
or 3 (more than 60 min). All participants completed a western
Ontario and McMaster Universities (WOMAC) OA index12
on the evening of admission. Weight and height were
recorded for computation of body mass index (BMI, kg/m2).
BLOOD SAMPLING
Blood was ﬁrst collected between 6:00 p.m. and 8:00
p.m. on the evening of admission to the GCRC, after
a normal day of activity and after eating. As this was the
latest sample of the day, this sample was designated T3.
Individuals retired to sleep at their usual hour, with
instructions to remain supine, at a minimum between 3:00
a.m. and 8:00 a.m. If necessary, a bedpan or urinal was
provided during this interval. At 8:00 a.m., participants were
awakened, and phlebotomy was performed while the
participant remained supine (T0). Immediately thereafter,
participants were served breakfast, and asked to performtheir usual daily routine. Phlebotomy was again performed
1 h after arising (T1), and 4 h after arising (T2). Participants
were encouraged to remain physically active throughout the
morning, and were not permitted to sit for more than 30 min
at a time. Sera were separated and immediately frozen to
20(C within 2 h of collection, then transferred to 86(C
for long-term storage.
HA ELISA ASSAY
Samples were analyzed for HA in duplicate, blinded, and
in random order using an indirect competitive enzyme-
linked immunosorbent assay (ELISA) as previously de-
scribed1. The inter- and intra-assay variability for this assay
were 13.6% and 6.3%, respectively.
STATISTICAL ANALYSIS
Statistical computations were performed using GraphPad
Prism (GraphPad Software, Inc., San Diego, CA) and
JMP (SAS, Cary, NC) software. Results were analyzed
using non-parametric Freidman’s test with Dunn’s post-hoc
Multiple Comparison Test (with Bonferroni correction). To
evaluate associations of HA with variables and risk factors
related to OA status (total WOMAC score, minutes of
morning stiffness, KeL sum score of the knees, total
numbers of OA joints, age and BMI), we performed multiple
linear regression. The change in HA levels with activity in
this cohort were compared to the levels reported in the
literature for RA patients and controls. A P value of !0.05
was considered signiﬁcant.
Results
A total of 20 participants (65% female, 80% Caucasian,
and 20% African American) with radiographic knee OA
underwent serial serum sampling within a 16-h period.
Participants ranged in age from 59 to 91 years (mean 70
years). A total of ﬁve (25%) participants had unilateral knee
OA, the remainder had bilateral disease. A total of seven
(35%) participants also had hip OA by clinical exam (100%
bilateral).
Serum HA levels varied up to a factor of 8 among
participants at any particular time point. However, upon
arising in the morning and performing typical daily activities
for 1 h, the serum HA levels rose in 17 of the 20 participants
(Fig. 1). The change in HA was signiﬁcant from T0, before
arising, to T1, after 1 h of morning activities (P! 0.01)
(Fig. 2). The tendency of serum HA levels to decrease after
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signiﬁcant. Mean serum levels of HA were 69G 43 ng/ml
(meanGSD) at T0, 136G 76 ng/ml at T1, 104G 63 ng/ml
at T2, and 86G 44 ng/ml at T3. The mean serum HA levels
in these OA participants were 2.5e5.4 times greater than
the mean level in a control population (NZ 298, mean HA
level of 25 ng/ml) that we have analyzed previously using
the same HA assay method1. The absolute levels of serum
HA are difﬁcult to compare among other studies utilizing
different assay methods; nevertheless, it is possible to
compare the magnitude of the increase in HA in response to
activity across these various studies. The magnitude of
change from T0 to T1 (1.98 times) in this cohort, was less
than the activity related increase reported for RA patients
(2.51e6.04 times), and comparable to or greater than the
increase reported for controls (1.43e2.08 times) (Table I).
In a multiple linear regression model, the only signiﬁcant
associations between the OA variables and HA in this small
sample were observed for the HA T3 value. Signiﬁcant
associations were observed between HA T3 and duration of
morning stiffness of the knees (parameter estimate
Fig. 1. Changes in serum HA with activity in individual participants
(NZ 20). T0 e 8:00 a.m. sample, prior to arising from bed; T1 e
9:00 a.m. sample, 1 h after arising from bed and performing morning
activities; T2 e 12:00 noon sample, 4 h after arising from bed; T3 e
8:00 p.m. sample, after approximately 12 h of daily activities.
Fig. 2. Serum HA levels over time. The box plots depict the median,
25th and 75th percentile values and upper and lower limits of serum
HA levels (expressed in ng/ml).bZ 33.5, PZ 0.02), the total WOMAC score (bZ1.41,
PZ 0.03), and weakly with KeL grade sum score (bZ 9.1,
PZ 0.09) but not with age. After the addition of BMI to the
model, the association of the HA T3 value with KeL grade
sum score was not signiﬁcant (PZ 0.17), but the associ-
ations with duration of morning stiffness of the knees and
total WOMAC score were unchanged.
Discussion
To our knowledge, this is the ﬁrst study to evaluate the
daily serum HA variation in a cohort of individuals with
radiographic knee OA. In this OA cohort, serum HA levels
rose signiﬁcantly with morning activities including eating
breakfast. This pattern is similar to the change in serum HA
observed for patients with RA5,8,13. In RA patients, the
magnitude of the transient increase in serum HA upon joint
mobilization was associated with the amount of synovitis
and duration of morning stiffness5. These ﬁndings have
been ascribed to accumulation of water with the hydrophilic
HA during joint immobilization in proportion to the amount of
inﬂamed joint tissue. It is speculated that this mechanism
results in hindered joint movement and the symptoms of
joint stiffness, which are alleviated as the joint is mobilized
and HA is transported via the lymphatics to the circulation.
We therefore believe the variations in HA with activity in OA
patients to be mechanistically similar, namely that HA
accumulates in lymph nodes, synovium, and subsynovial
tissues of OA joints during rest, as has been postulated for
RA7, and is transported via the lymphatics to the circulation
during physical activity.
Several past studies have provided insight into the
variability in serum HA due to assumption of an upright
posture14, activity15, and eating16, all of which lead to
increases in serum HA. Increases in serum HA with activity
were more pronounced in individuals with inﬂammatory
arthritis than normal controls, as demonstrated by Eng-
strom-Laurent and Hallgren et al.5, Manicourt et al.6 and
Lindqvist et al.8. By changing the time of the ﬁrst meal of the
day, Rossler et al.16 were able to change the time of day of
the serum HA peak in ﬁve healthy males. When standard
portions were provided to resting individuals, HA increased
1 h after the ﬁrst meal of the day, and did not increase with
further meals. When meals were supplied in small aliquots
every 30 min rather than as one large meal, peak serum HA
levels were attenuated, though the only signiﬁcant change
still occurred 1 h after the ﬁrst feeding. These studies
together suggest that serum HA levels are inﬂuenced by
both the ﬁrst food intake and the ﬁrst episode of mobilization
of the day, independent of the actual time of day. In this
regard, the variation in HA is not strictly diurnal but rather
activity related. Based upon these results, and insights
derived from past studies, we suggest serum sampling for
HA more than 1 h after arising and becoming active in the
morning and at least 1 h after breaking an overnight fast.
The HA macromolecule exists as a stiff random coil in
solution17. Conformational changes in HA, induced by oxidation
or by digestion into smaller fragments, can alter the apparent
HA concentration as measured with an HA-protein binding
assay of the type used in this study17,18, presumably as
a result of unmasking new HA-protein binding sites. It has
been shown that a minimum of 10 HA-derived oligosaccha-
ride units are needed to bind to an HA-binding protein, and
the ability to bind diminishes above a size of 100 HA-
derived oligosaccharide units17. In RA patients, the tran-
sient peak in response to morning activity consists of
840 L. G. Criscione et al.: Variation of serum hyaluronan in OArelatively low molecular weight HA13, a size probably readily
detected by a HA-protein binding assay. Thus the apparent
concentrations of HA, and in particular, the transient rise in
the morning after 1 h of activity, may reﬂect both the
quantity of HA and the size and conformation of HA.
A limitation of our study was the small sample size that
limited our ability to ﬁnd relationships of statistical signiﬁ-
cance between HA levels and OA variables. However, the
repeated measures design increased the study power to
detect diurnal changes in HA levels. In summary, our study
demonstrates variation in serum HA in an OA population in
response to activities of daily living in the morning. These
results suggest that serum HA levels drawn more than 1 h
after arising can be considered representative of a stable
level of this OA biomarker in individuals with knee and hip
OA.
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